NeOnc Technologies Holdings is trading 6.4% up at $4.99, after rising from the August 28 close of $4.69; the immediate catalyst is unclear.

  • No new company-specific announcement was identified for August 31, 2026.
  • Recent coverage centers on encouraging August 12 NEO100 Phase 2a results, including 48.9% six-month progression-free survival versus a 20% historical benchmark.
  • Broader U.S. markets are trading lower.